RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación
Artículo científico (JournalArticle)
State of the Art of Artificial Intelligence in Clinical Electrophysiology in 2025: A Scientific Statement of the European Heart Rhythm Association (EHRA) of the ESC, the Heart Rhythm Society (HRS), and the ESC Working Group on E-Cardiology
[EN] Aims Artificial intelligence (AI) has the potential to transform cardiac electrophysiology (EP), particularly in arrhythmia detection, procedural optimization, and patient outcome prediction. However, a standardized approach to reporting and understanding AI-related research in EP is lacking. This scientific statement aims to develop and apply a checklist for AI-related research reporting in EP to enhance transparency, reproducibility, and understandability in the field. Methods and results An AI checklist specific to EP was developed with expert input from the writing group and voted on using a modified Delphi process, leading to the development of a 29-item checklist. The checklist was subsequently applied to assess reporting practices to identify areas where improvements could be made and provide an overview of the state of the art in AI-related EP research in three domains from May 2021 until May 2024: atrial fibrillation (AF) management, sudden cardiac death (SCD), and EP lab applications. The EHRA AI checklist was applied to 31 studies in AF management, 18 studies in SCD, and 6 studies in EP lab applications. Results differed between the different domains, but in no domain reporting of a specific item exceeded 55% of included papers. Key areas such as trial registration, participant details, data handling, and training performance were underreported (<20%). The checklist application highlighted areas where reporting practices could be improved to promote clearer, more comprehensive AI research in EP. Conclusion The EHRA AI checklist provides a structured framework for reporting AI research in EP. Its use can improve understanding but also enhance the reproducibility and transparency of AI studies, fostering more robust and reliable integration of AI into clinical EP practice.; [GRAPHICS]; ., E.S. is supported by the Stockholm County Council (Clinical researcher appointment), the Swedish Research Council (DNR 2022-01466), the Swedish Heart and Lung foundation, CIMED, S.E. is supported by research grants from German Center for Cardiovascular Research (DZHK), the Carl-Zeiss Foundation in the project Multi-dimension AI. J Millet (e-cardiology) reports grant support PID2022-142514OB-I00 from Spanish Research Agency. Professor GA Ng reports grant support from the British Heart Foundation [Research Excellence Award (RE/24/13003) and Healthcare Innovation Fund (HI/C2/24/360038)], the National Institute for Health and Care Research Invention for Innovation Award (NIHR204553). F.V.Y.T. is supported by personal research grants from the Dutch Research Council (NWO), Amsterdam Cardiovascular Sciences, and Health Holland. J.R. acknowledges funding from the European Union-NextGenerationEU, fellowship RYC2021-031413-I from MCIN/AEI/10.13039/501100011033, and from the European Union "NextGenerationEU/PRTR" and from grants PID2021-128972OA-I00, CNS2023-143599 and PID2023-148975OB-I00, funded by MCIN/AEI/10.13039/501100011033. N.T. (HRS) is supported by NIH grants R01HL166759 and R01HL174440 and a grant from the Leducq Foundation.
Proyecto:
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2021-128972OA-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2022-142514OB-I00
,
Agencia Estatal de Investigación / Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 PID2023-148975OB-I00
,
National Institutes of Health / NATIONAL_HEART 1R01HL166759-01
,
EEUU / _LUNG 1R01HL174440-01
,
National Institutes of Health / _AND_BLOOD_INSTITUTE NIHR204553
,
EEUU / NATIONAL_HEART DNR 2022-01466
,
National Institute for Health Research / _LUNG RE/24/13003
,
Reino Unido / _AND_BLOOD_INSTITUTE HI/C2/24/360038
,
Swedish Research Council RYC2021-031413-I
,
British Heart Foundation CNS2023-143599